bioMérieux S.A. (OTCMKTS:BMXMF) Short Interest Down 10.2% in January

bioMérieux S.A. (OTCMKTS:BMXMF) was the target of a significant decrease in short interest in the month of January. As of January 31st, there was short interest totalling 104,300 shares, a decrease of 10.2% from the January 15th total of 116,100 shares. Based on an average daily volume of 4,900 shares, the days-to-cover ratio is presently 21.3 days.

bioMérieux Stock Performance

OTCMKTS:BMXMF opened at $116.75 on Tuesday. The company’s 50 day moving average price is $111.60 and its 200-day moving average price is $111.44. bioMérieux has a 52 week low of $93.50 and a 52 week high of $123.44. The company has a current ratio of 2.21, a quick ratio of 1.20 and a debt-to-equity ratio of 0.10.

About bioMérieux

bioMérieux SA develops and produces in vitro diagnostic solutions for the diagnosis of infectious diseases in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers systems that use biological samples, such as blood, saliva, urine, etc. for the diagnosis of infectious diseases, including bacterial infections, parasitic infections, and viral infections; and microbiological control of production or the production environment primarily for food, pharmaceutical, and cosmetic industries.